Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
The Risk of Hypothyroidism With the Use of GLP ‐1 Receptor Agonists in Saudi Arabia
The Risk of Hypothyroidism With the Use of GLP ‐1 Receptor Agonists in Saudi Arabia
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Almaha Alfakhri
,
Ohoud Almadani
,
Raseel Alroba
,
Adel Alrwisan
,
Omar Alshaya
,
Yasser Albogami
Format:
Artículo Open Access
Published:
Wiley
2026
Subjects:
Pharmacoepidemiology and Drug Safety
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Real‐World Evidence of Indapamide‐Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health Records
by: Raseel Alroba, et al.
Published: (2024)
Prevalent‐New User Design for Biosimilar Safety Using Saudi Real‐World Data
by: Ohoud Almadani, et al.
Published: (2026)
Glucagon‐Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Among Type 2 Diabetes Patients: Replication and Reliability Assessment Across a Research Network
by: Mitchell M. Conover, et al.
Published: (2025)
Assessing Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Incidence of Major Adverse Cardiovascular Events: A Retrospective Cohort Study
by: Aljoharah M. Algabbani, et al.
Published: (2025)
Comparative Safety of Glucagon‐Like Peptide 1 Receptor Agonists ( GLP ‐1‐ RAs ) in Type 2 Diabetes and Chronic Weight Management: A Real‐World Data Study
by: Sarah Ruth Hurwitz, et al.
Published: (2025)